Combination of 90Y- and 177Lu-labeled somatostatin analogs is superior for radionuclide therapy compared to 90Y- or 177Lu-labeled analogs only.

被引：0
|
作者：
De Jong, M [1 ]
Bernard, HF [1 ]
Breeman, WA [1 ]
Van Gameren, A [1 ]
Krenning, EP [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
来源：
JOURNAL OF NUCLEAR MEDICINE | 2002年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
446
引用
收藏
页码：123P / 124P
页数：2
相关论文
共 50 条
  • [21] Preliminary evaluation of 177Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy
    Lei Jiang
    Zheng Miao
    Richard H. Kimura
    Hongguang Liu
    Jennifer R. Cochran
    Cathy S. Culter
    Ande Bao
    Peiyong Li
    Zhen Cheng
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 613 - 622
  • [22] Labelling of 90Y- and 177Lu-DOTA-Bioconjugates for Targeted Radionuclide Therapy: A Comparison among Manual, Semiautomated, and Fully Automated Synthesis
    Iori, Michele
    Capponi, Pier C.
    Rubagotti, Sara
    Esposizione, Luca Rosario
    Seemann, Johanna
    Pitzschler, Riccardo
    Dreger, Thorsten
    Formisano, Debora
    Grassi, Elisa
    Fioroni, Federica
    Versari, Annibale
    Asti, Mattia
    CONTRAST MEDIA & MOLECULAR IMAGING, 2017, : 1 - 12
  • [23] A 47Sc-labeled GRPR Antagonist with Superior SPECT Imaging Characteristics Compared to its 177Lu-labeled Counterpart
    Lappchen, T.
    Pilatis, E.
    Menendez, E.
    Bilinska, A.
    D'Onofrio, A.
    Moon, E.
    Zoltowska, M.
    Pawlak, D.
    Cieszykowska, I.
    Mikolajczak, R.
    Roesch, F.
    Rominger, A.
    Gourni, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S319 - S320
  • [24] 177Lu- vs 90Y- Octreotide derivatives: experimental data and theoretical considerations on the most appropriate radionuclide in receptor radiotherapy
    Cremonesi, M.
    Bodei, L.
    Bartolomei, M.
    Ferrari, M.
    Chinol, M.
    Caracciolo, M.
    Tosi, G.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S201 - S201
  • [25] Comparison of the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in the preclinical setting
    Busslinger, Sarah D.
    Mapanao, Ana Katrina
    Kegler, Kristel
    Bernhardt, Peter
    Fluhmann, Fabienne
    Fricke, Julia
    Zeevaart, Jan Rijn
    Koester, Ulli
    van der Meulen, Nicholas P.
    Schibli, Roger
    Mueller, Cristina
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (13) : 4049 - 4061
  • [26] Anaerobic 90Y- and 177Lu-labeling of a DOTA-conjugated nonpeptide vitronectin receptor antagonist
    Liu, S
    Harris, TD
    Ellars, CE
    Edwards, DS
    BIOCONJUGATE CHEMISTRY, 2003, 14 (05) : 1030 - 1037
  • [27] Radionuclide Therapy Using 177Lu-labeled ABD-fused ADAPT6 Scaffold Protein
    Garousi, J.
    Von Witting, E.
    Oroujeni, M.
    Borin, J.
    Vorobyeva, A.
    Altai, M.
    Vorontsova, O.
    Konijnenberg, M. W.
    Orlova, A.
    Hober, S.
    Tolmachev, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S649 - S650
  • [28] Acidity-Activated Charge Conversion of 177Lu-Labeled Nanoagent for the Enhanced Photodynamic Radionuclide Therapy of Cancer
    Zhang, Yuan
    Wang, Guanglin
    Li, Qing
    Jiang, Yue
    Chen, Wan
    Zhao, Min
    Liang, Gaolin
    Miao, Qingqing
    ACS APPLIED MATERIALS & INTERFACES, 2022, 14 (03) : 3875 - 3884
  • [29] Design, preparation and biological evaluation of a 177Lu-labeled somatostatin receptor antagonist for targeted therapy of neuroendocrine tumors
    Behnammanesh, Hossein
    Jokar, Safura
    Erfani, Mostafa
    Geramifar, Parham
    Sabzevari, Omid
    Amini, Mohsen
    Mazidi, Seyed Mohammad
    Hajiramezanali, Maliheh
    Beiki, Davood
    BIOORGANIC CHEMISTRY, 2020, 94
  • [30] Bioinspired Synthesis of Intrinsically 177Lu-Labeled Hybrid Nanoparticles for Potential Cancer Therapy
    Chakravarty, Rubel
    Guleria, Apurav
    Jadhav, Sachin
    Kumar, Chandan
    Debnath, Anil Krishna
    Sarma, Haladhar Dev
    Chakraborty, Sudipta
    INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2020, 59 (52) : 22492 - 22500
12345